Third Point LLC bought a new stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 385,000 shares of the biotechnology company’s stock, valued at approximately $37,122,000. BioMarin Pharmaceutical accounts for about 0.6% of Third Point […]
Third Point LLC bought a new stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 385,000 shares of the biotechnology company’s stock, valued at approximately $37,122,000. BioMarin Pharmaceutical accounts for about 0.6% of Third Point […]
Artia Global Partners LP decreased its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 63.2% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 28,885 shares of the biotechnology company’s stock after selling 49,580 shares during the period. BioMarin Pharmaceutical makes up about […]
Avoro Capital Advisors LLC grew its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 11.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 4,300,000 shares of the biotechnology company’s stock after purchasing an additional 450,000 shares during the period. […]
Avoro Capital Advisors LLC boosted its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 11.7% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 4,300,000 shares of the biotechnology company’s stock after purchasing an additional 450,000 shares during the quarter. […]